(when cruising in the 21st century)

This pharma company is not different from other companies except that it may have gone public a nudge to early; did not make it over the critical hurdle; the share price fell apart a few months after the final road show. So apart from struggling with product development and staff problems, Tom, the eager young MBA at the rudder, is increasingly feeling the pressure from the board and main owners over the poor stock performance.


The investment bank got it all wrong; going public was not heaven. In fact, it was the basement nest to hell; and the problems started when the company went public.

It is clear that too many companies go public without a real plan for stakeholder engagement.

Read more about this in EQapital.se


Share This: